NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
46 hedge funds and large institutions have $13.6M invested in Niagen Bioscience, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
-6
Holders Change %
-11.54%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
16
Reduced
12
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
+$3.27M |
2 |
TCM
Tieton Capital Management
Yakima,
Washington
|
+$1.85M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$105K |
4 |
![]()
RhumbLine Advisers
Boston,
Massachusetts
|
+$82.9K |
5 |
Barclays
London,
United Kingdom
|
+$29.6K |